SCHEMBL21393588

SCHEMBL21393588

Cn1ncc2nc(N)n(S)c(=O)c21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
TRPA1 O75762 2/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
KDM4E B2RXH2 1/20 0.36
DPP4 P27487 1/20 0.32
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
BPTF Q12830 1/20 0.31
KAT2B Q92831 1/20 0.30
BRD9 Q9H8M2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21393582 0.83 KDM4E (0.49) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL22477732 0.78 ALDH1A1 (0.38) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL22477705 0.78 ALDH1A1 (0.39) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL21363587 0.78 ALDH1A1 (0.39) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL30814728 0.68 TLR8 (0.39) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL26155930 0.68 QTRT1 (0.42) ALDH1A1KDM4ELMNA
SCHEMBL9466617 0.67 ADORA2A (0.38) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL25165851 0.65 KDM4E (0.41) ALDH1A1ADORA3ADORA2AADORA2BADORA1
SCHEMBL21363488 0.63 ALDH1A1 (0.41) ALDH1A1ADORA2AADORA1TRPA1CYP1A2
SCHEMBL4402726 0.63 KMT2A (0.41) ALDH1A1CYP1A2POLBCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182925-A1 OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS GENENTECH, INC. (US) 2019-09-26 WO disclosed